Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
2.850
+0.040 (1.42%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Scinai Immunotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
2310433293
Upgrade
Market Cap Growth
-17.93%-74.89%-76.24%34.05%-65.34%199.75%
Upgrade
Enterprise Value
316195559105
Upgrade
Last Close Price
2.815.9529.60235.00281.00929.00
Upgrade
PB Ratio
0.24-0.57-5.8644.22-2.22-1.44
Upgrade
P/TBV Ratio
0.29--44.22--
Upgrade
EV/EBITDA Ratio
---6.62-
Upgrade
EV/EBIT Ratio
---7.98-
Upgrade
Debt / Equity Ratio
0.12-4.50-12.2429.52-4.60-2.02
Upgrade
Debt / EBITDA Ratio
----6.87-
Upgrade
Quick Ratio
0.832.946.077.150.153.84
Upgrade
Current Ratio
1.163.066.157.300.173.86
Upgrade
Return on Equity (ROE)
128.46%-----
Upgrade
Return on Assets (ROA)
-33.23%-27.24%-23.39%-26.97%5.31%-44.20%
Upgrade
Return on Capital (ROIC)
-36.15%-33.91%-27.79%-28.97%7.72%-75.70%
Upgrade
Earnings Yield
195.92%-250.86%-56.18%-18.90%-13.75%-116.85%
Upgrade
FCF Yield
-280.78%-386.66%-78.52%-17.42%-242.88%-90.41%
Upgrade
Buyback Yield / Dilution
-57.22%-107.22%-33.56%-27.37%-35.70%-24.95%
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q